STOCKHOLM, Sweden--(BUSINESS WIRE)--Sept. 23, 2005--Norwegian life sciences company DiaGenic ASA (OSE:DIAG) today announced it was awarded first place for its poster presentation “Detection of Alzheimer’s disease based on gene expression patterns in peripheral blood cells” at the International Psychogeriatric Association’s (IPA) 12th Congress in Stockholm. The data DiaGenic ASA presented at IPA shows that its patented method to develop gene expression (Editor’s notes 1 and 2) signatures using peripheral blood samples can be applied to detect Alzheimer’s disease. This makes the development of a blood test for Alzheimer’s disease a possibility for the first time.
